Home / Health / Allergy Med Recall: Life-Threatening Contaminant Found
Allergy Med Recall: Life-Threatening Contaminant Found
21 Jul
Summary
- Four lots of allergy tablets recalled due to possible contamination.
- Contaminant could cause severe hypersensitivity and life-threatening reactions.
- No adverse incidents reported yet, but consumers urged to check medication.
Four lots of cetirizine hydrochloride tablets, commonly used for allergy symptoms, are being recalled due to potential contamination. Unique Pharmaceutical Laboratories initiated the voluntary recall after discovering the medication may have been cross-contaminated with ranitidine.
Ranitidine, while used for conditions like ulcers and heartburn, carries a risk of severe adverse events, including anaphylaxis, for hypersensitive individuals. Symptoms can be life-threatening, encompassing difficulty breathing, swelling, and loss of consciousness.
The recalled tablets were distributed nationwide in 100-count bottles. A pharmacy technician reportedly identified the issue through visual discrepancies. The company has notified affected customers and arranged for returns. Consumers with questions can contact Rising Pharma Holdings directly.
This recall follows a 2020 FDA action that removed ranitidine from the market due to concerns about N-Nitrosodimethylamine (NDMA), a potential carcinogen. A reformulated ranitidine tablet was later approved in 2025.
